Market Research Logo

Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States

This report focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the progress that is being made in these fields. The major market effects of new therapeutics, with the potential of a breakthrough drug always a possibility, are expected to be seen over the next ten years. The technology trends selected in conjunction with the growing interest in psoriasis and its treatment present the most informative picture of advances in psoriasis and psoriatic arthritis therapeutics and the markets that result.

The report’s market analysis includes:

  • extensive discussion of the pathology of the multiple forms of the disease
  • thorough examination of the epidemiology in the United States segmented by severity and projected to 2016
  • comprehensive analysis of the total available market and serviceable available market for psoriasis (by severity) and psoriatic arthritis through 2016
  • monthly cost per patient forecasts for psoriasis (by severity) and psoriatic arthritis through 2016

In depth company profiles of major competitors and a meticulous review of the expert conclusions and strategic implications for competitors serious about winning in the psoriasis therapeutics field round out this systematic analysis.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including immunologists, dermatologists, rheumatologists, pathologists, research scientists, business development managers and marketing managers.


  • Executive Summary
    • OVERVIEW
    • TYPES
      • Table Prevalence of Psoriasis and Psoriatic Arthritis in the United States 2006-2016
      • Table Common Psoriasis Treatments
    • SCOPE AND METHODOLOGY
    • MARKET ANALYSIS
      • Table The Total Available Market for Psoriasis and Psoriatic Arthritis Therapeutics in the United States by Severity 2006-2016
      • Table Serviceable Available Market (SAM) for Psoriasis and Psoriatic Arthritis Therapeutics in the United States by Severity 2006-2016
    • TRENDS AND CONSIDERATIONS
  • Pathology and Epidemiology
    • OVERVIEW
      • Tumor Necrosis Factor a
      • Contributing Factors
      • National Psoriasis Foundation Survey
    • PATHOLOGY OF PSORIASIS
      • Types
        • Table Types of Psoriasis and Their Characteristics
      • Types by Location
      • Types by Severity
        • Table Psoriasis Assessment Methods
    • PATHOLOGY OF PSORIATIC ARTHRITIS
      • Table Type of Psoriatic Arthritis (PsA) and Their Characteristics
    • THE GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
    • PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY
      • Table Prevalence of Psoriasis and Psoriatic Arthritis in the United States by Type 2006-2016
  • Current Therapies
    • Table Psoriasis and Psoriatic Arthritis Therapeutics and Treatment Products
    • Table The Psoriasis Treatment Ladder
    • TOPICAL THERAPY
      • Anthralin
      • Calcipotriene
      • Coal Tar
      • Salicylic Acid
      • Corticosteroids (Steroids)
      • Vitamin A
        • Table Steroid Potency Classes and Products
      • Sunlight and Water (Climatotherapy)
    • PHOTOTHERAPY
      • UV-B Therapy
        • Table Phototherapy Skin Types
      • PUVA
        • Table Phototherapy Equipment Manufacturers
    • SYSTEMIC TREATMENTS
      • Corticosteroids
      • Cyclosporine
      • Methotrexate
      • Retinoids
      • Aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Biological DMARDS
        • Table Comparison of Biological Therapeutics for Psoriasis and Psoriatic Arthritis
    • NEW DEVELOPMENTS
    • ALTERNATIVE THERAPIES
      • Table Treatments in Development for Psoriasis and Psoriatic Arthritis
      • Acupuncture
      • Ayurvedic Medicine
      • Chinese Medicine
      • Chiropractic
      • Homeopathic Medicine
      • Naturopathic Medicine
      • Glucosamine and Chondroitin
      • Methylsulfonylmethane (MSM)
      • S-adenosylmethionine (SAM-e)
      • Magnetic Therapy
  • Market Analysis
    • FORECASTING CHALLENGES
    • MARKET SIZE AND COST OF TREATMENT
      • Table Total Available Market (TAM) for Psoriasis (by Severity) and Psoriatic Arthritis Therapeutics in the United States 2006-2016
      • Table Estimated Monthly Cost per Patient for the Medicinal Treatment of Psoriasis (by Severity) and Psoriatic Arthritis in the United States2006-2016
    • TOTAL AVAILABLE MARKET VS SERVICEABLE AVAILABLE MARKET
      • Table Serviceable Available Market (SAM) for Psoriasis (by Severity) and Psoriatic Arthritis Therapeutics in the United States: 2006-2016
    • COMPETITION
      • Table Active Competitors in Ethical Pharmaceuticals for Psoriasis and Psoriatic Arthritis in the United States
  • Company Profiles
    • AMGEN
    • ANGIOTECH PHARMACEUTICALS
    • BIOGEN IDEC
    • CENTOCOR, INC.
    • GALDERMA LABORATORIES
    • ISIS PHARMACEUTICALS, INC.
    • ISOTECHNIKA, INC.
    • LIGAND PHARMACEUTICALS
    • VERTEX PHARMACEUTICALS
  • Conclusions and Strategic Implications
    • FIRST CONCLUSION
      • Implications:
    • SECOND CONCLUSION
      • Implications:
    • THIRD CONCLUSION
      • Implications:
    • FOURTH CONCLUSION
      • Implications:
    • FIFTH CONCLUSION
      • Implications:
    • SIXTH CONCLUSION
      • Implications:
    • SEVENTH CONCLUSION
      • Implications:
    • EIGHTH CONCLUSION
      • Implications:
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report